Literature DB >> 22673235

Hypoxia-inducible factor-1 alpha in the heart: a double agent?

Satwat Hashmi1, Suhail Al-Salam.   

Abstract

Hypoxia-inducible factor (HIF) is a set of transcription factors that regulate the cellular response to hypoxia. There is a great body of evidence supporting the protective role of HIF-1α in cardiovascular pathophysiology, however, newer studies are hinting at a maladaptive and deleterious role of this transcription factor that merits further investigation. There is a general agreement, however, that HIF-mediated responses appear to differ under conditions of acute and chronic oxygen deprivation. The intensity and sustainability of HIF-1α activation are major determinants of whether the responses are pathological or beneficial. HIF activation is seen to be beneficial in the setting of acute myocardial ischemia and deleterious in chronic conditions. In this review, we will focus on recent insights into the role of HIF-1α in the heart and especially in the setting of ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673235     DOI: 10.1097/CRD.0b013e31826287f6

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  10 in total

Review 1.  Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.

Authors:  Sergiu-Bogdan Catrina
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

Review 2.  Selenoproteins and cardiovascular stress.

Authors:  Aaron H Rose; Peter R Hoffmann
Journal:  Thromb Haemost       Date:  2014-10-30       Impact factor: 5.249

3.  Galectin-1: a biomarker of surgical stress in murine model of cardiac surgery.

Authors:  Satwat Hashmi; Suhail Al-Salam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Allicin attenuates myocardial apoptosis, inflammation and mitochondrial injury during hypoxia-reoxygenation: an in vitro study.

Authors:  Xinyi Deng; Peng Yang; Tong Gao; Mengru Liu; Xianlun Li
Journal:  BMC Cardiovasc Disord       Date:  2021-04-21       Impact factor: 2.298

5.  The role of miR-711 in cardiac cells in response to oxidative stress and its biogenesis: a study on H9C2 cells.

Authors:  Duo Zhao; Hao Zheng; Adam Greasley; Fengjun Ling; Qinfeng Zhou; Bowen Wang; Tiffany Ni; Ishita Topiwala; Cuilin Zhu; Tina Mele; Kexiang Liu; Xiufen Zheng
Journal:  Cell Mol Biol Lett       Date:  2020-04-09       Impact factor: 5.787

6.  Olmesartan restores the protective effect of remote ischemic perconditioning against myocardial ischemia/reperfusion injury in spontaneously hypertensive rats.

Authors:  Xin Lu; Yan-Wen Bi; Ke-Biao Chen
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

7.  Galectin-1 in early acute myocardial infarction.

Authors:  Suhail Al-Salam; Satwat Hashmi
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

8.  Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy.

Authors:  S Gallo; S Gatti; V Sala; R Albano; P Costelli; E Casanova; P M Comoglio; T Crepaldi
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

9.  Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia.

Authors:  Heng-Chen Yao; Min Zhou; Yan-Hong Zhou; Lan-Hua Wang; De-Yong Zhang; Qian-Feng Han; Tao Liu; Lei Wu; Ke-Li Tian; Mei Zhang
Journal:  Mol Med Rep       Date:  2015-12-07       Impact factor: 2.952

10.  Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway.

Authors:  Qian Zhang; Dongqing Guo; Yuanyuan Wang; Xiaoping Wang; Qiyan Wang; Yan Wu; Chun Li; Wei Wang; Yong Wang
Journal:  Front Pharmacol       Date:  2020-04-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.